Specialized oncology research and development focusing on cancer therapeutics, precision medicine, and targeted therapies. This segment includes immunotherapy, chemotherapy, and novel cancer treatment approaches.

Gastroenterological research and development including treatments for inflammatory bowel disease, liver conditions, and digestive disorders. This segment addresses complex GI conditions.

Comprehensive neuroscience operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the neuroscience field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.

Dedicated rare disease research and orphan drug development addressing unmet medical needs. This segment focuses on genetic disorders, rare cancers, and conditions affecting small patient populations.